Clincosm LogoSign in Get a demo

Melanoma

Showing 26 - 50 of 1,172
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Trial in United States (IO102/IO103, Nivolumab-Relatlimab)

Recruiting
  • Melanoma
  • Basking Ridge, New Jersey
  • +6 more
Jun 23, 2023

Melanoma Trial (ABP 206, FDA-licensed Nivolumab, EU-authorized Nivolumab)

Not yet recruiting
  • Melanoma
  • ABP 206
  • +2 more
  • (no location specified)
Jun 8, 2023

Melanoma, Hepatocellular Carcinoma (HCC), Renal Cell Carcinoma (RCC) Trial (INCB 99280 with Ipilimumab)

Not yet recruiting
  • Melanoma
  • +5 more
  • INCB 99280 with Ipilimumab
  • (no location specified)
Jun 9, 2023

HNSCC, Melanoma, Gynecologic Cancer Trial in Portland (DP CD8 TIL, DP CD8 TIL KD, Low dose IL-2)

Recruiting
  • HNSCC
  • +5 more
  • DP CD8 TIL
  • +2 more
  • Portland, Oregon
    Providence Portland Medical Center
Jun 5, 2023

EVALUATING THE CURRENT STANDARD OF CARE FOR PATIENTS DIAGNOSED

Not yet recruiting
  • Melanoma (Skin)
  • Melanoma
    • (no location specified)
    Jun 2, 2023

    Melanoma Trial (Tranexamic acid, Saline)

    Not yet recruiting
    • Melanoma
    • (no location specified)
    Jun 2, 2023

    NSCLC, HNSCC, Melanoma Trial (CJRB-101, Pembrolizumab injection)

    Not yet recruiting
    • NSCLC
    • +5 more
    • (no location specified)
    Jun 1, 2023

    Skin Health and Quality of Life in Patients Receiving

    Not yet recruiting
    • Lung Cancer
    • +7 more
    • EQ-5D-5L questionnaire
    • +2 more
    • Roma, Italy
      Roberto Iacovelli
    May 17, 2023

    Blocking TNF to Potentiate ICI-dependent Immune Awakening in

    Recruiting
    • Melanoma
    • +2 more
      • Toulouse, France
        Institut Claudius Regaud
      May 25, 2023

      Healthcare Resource Utilization and Costs of Immune Checkpoint

      Completed
      • Melanoma
        • East Hanover, New Jersey
          Novartis
        May 12, 2023

        Solid Tumor, Adult, Advanced Solid Tumor, Head Neck Cancer Trial in Irving, San Antonio, West Valley City (SNS-101 (anti-VISTA),

        Recruiting
        • Solid Tumor, Adult
        • +19 more
        • Irving, Texas
        • +2 more
        May 24, 2023

        Melanoma Trial in Beijing, Nanjing, Hangzhou (OH2, Salvage chemo or best supportive care)

        Recruiting
        • Melanoma
        • OH2
        • Salvage chemotherapy or best supportive care
        • Beijing, Beijing, China
        • +2 more
        May 11, 2023

        Cutaneous Squamous Cell Carcinoma, SCC - Squamous Cell Carcinoma, Basal Cell Carcinoma Trial in United States (MQ719,

        Recruiting
        • Cutaneous Squamous Cell Carcinoma
        • +18 more
        • Basking Ridge, New Jersey
        • +6 more
        May 18, 2023

        Melanoma, Urothelial Carcinoma, Renal Cell Carcinoma Trial in Auchenflower (RC198 Injection)

        Not yet recruiting
        • Melanoma
        • +5 more
        • RC198 Injection
        • Auchenflower, Queensland, Australia
          Research Site
        May 17, 2023

        Genomic Data of American Indian Patient Population

        Active, not recruiting
        • Immune Checkpoint Inhibitors
        • +6 more
        • Immunotherapy
        • Tucson, Arizona
        • +5 more
        May 8, 2023

        Melanoma, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in Australia (AI-061)

        Not yet recruiting
        • Melanoma
        • +16 more
        • Darlinghurst, New South Wales, Australia
        • +3 more
        May 12, 2023

        Melanoma Trial in Charlottesville (Excision of clinically detected lymph node metastasis before any systemic therapy, Excision

        Not yet recruiting
        • Melanoma
        • Excision of clinically detected lymph node metastasis before any systemic therapy
        • Excision of clinically detected lymph node metastasis after neoadjuvant systemic therapy
        • Charlottesville, Virginia
          Cancer Center at the University of Virginia
        Apr 20, 2023

        Invasive Ductal Breast Carcinoma, Invasive Ductal Breast Carcinoma Stage IV, Lobular Breast Carcinoma Trial in United States

        Recruiting
        • Invasive Ductal Breast Carcinoma
        • +14 more
        • Stereotactic body radiotherapy
        • Lattice Radiation Therapy
        • Basking Ridge, New Jersey
        • +6 more
        Apr 20, 2023

        Lung Non-Small Cell Carcinoma, Malignant Solid Tumor, Melanoma Trial in Duarte (procedure, other, radiation)

        Not yet recruiting
        • Lung Non-Small Cell Carcinoma
        • +3 more
        • Biospecimen Collection
        • +4 more
        • Duarte, California
          City of Hope Medical Center
        Apr 13, 2023

        Melanoma Trial (Cancer Patients Better Life Experience (CAPABLE))

        Not yet recruiting
        • Melanoma
        • Cancer Patients Better Life Experience (CAPABLE)
        • (no location specified)
        Apr 11, 2023

        Melanoma, Urothelial Carcinoma Trial in China (QLF31907)

        Not yet recruiting
        • Melanoma
        • Urothelial Carcinoma
        • Beijing, Beijing, China
        • +5 more
        Apr 9, 2023

        TRAQinform Assessment of Immunotherapy Response

        Not yet recruiting
        • Melanoma
        • Non-Interventional
        • (no location specified)
        Apr 6, 2023

        Relation to Sentinel Lymph Node Biopsy in Melanoma;Pilot Study

        Completed
        • Melanoma
        • Surgery
        • Blood samples
        • Aalborg, The North Denmark Region, Denmark
          Aalborg University Hospital
        Apr 5, 2023

        Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in

        Not yet recruiting
        • Head and Neck Cancer
        • +8 more
        • Tumor and HLA Profiling
        • (no location specified)
        Mar 31, 2023

        Melanoma, BRAF V600 Mutation, Unresectable Melanoma Trial in Rennes (Binimetinib Oral Tablet)

        Completed
        • Melanoma
        • +3 more
        • Binimetinib Oral Tablet
        • Rennes, France
          Biotrial
        Mar 31, 2023